Study: Treatments for Hep C Improving

Article

WASHINGTON, D.C. - A committee convened by the National Institutes of Health (NIH) has found that treatment for the hepatitis C virus (HCV) has significantly improved during the past five years.

Sustained response rates have reportedly increased from 15 percent to 50 percent from treatment with combination therapies. Specifically, interferon and the antiviral drug ribavirin have improved the treatment of patients dramatically.

HCV, which is the leading cause of liver disease and liver cancer, has infected an estimated 4 million Americans.

Information from www.azcentral.com

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content